Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapy-Reference-Cited by-同舟云学术

Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapy

Author:

Bialkowski Lukasz¹^ORCID,Van der Jeught Kevin¹,Bevers Sanne²,Tjok Joe Patrick¹,Renmans Dries¹,Heirman Carlo²,Aerts Joeri L.¹,Thielemans Kris¹²

Affiliation:

1. Laboratory of Molecular and Cellular Therapy; Vrije Universiteit Brussel, Laarbeeklaan 103E; Brussels 1090 Belgium

2. eTheRNA Immunotherapies, Galileilaan 19; Niel 2845 Belgium

Funder

IWT-Vlaanderen, Interuniversity Attraction Poles Program

National Cancer Plan

Stichting Tegen Kanker

Vlaamse Liga Tegen Kanker

Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO-Vlaanderen)

Hercules Foundation Flanders (Middelzware onderzoeksinfrastructuur)

EU FP7-Cancer Immunotherapy Program

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference55 articles.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献